You are here

MOEBIO

In recent years, our knowledge in the life sciences has increased exponentially and technology has become increasingly complex. At the same time, providing quality healthcare has become an ever more difficult and expensive process. There are many medical needs, some obvious and others that have not been identified even by the people closest to them. Prostheses that are more comfortable and less visible, wearable devices, mobile apps that help patients stick to their treatment regimen and more: the healthcare revolution offers great opportunities for innovation and entrepreneurship. 

www.moebio.org 

dhealth home

The revolution in the health sector also includes training future professionals in the sector. The new generations of healthcare innovators don’t learn in classrooms; they learn in operating and emergency rooms. In 2001, Stanford University created the first biodesign program, a unique innovation methodology in which students participate in the daily operations at a hospital to detect unmet clinical needs in situ and use them as the basis to design new products or services they later develop through the program. The Stanford Biodesign Fellowship has led to the creation of nearly 40 companies, which have generated more than $325 millions in investment and products that have been used to treat more than 275,000 patients.

Inspired by this prestigious program, in 2013 Biocat launched the Moebio talent-development initiative and its flagship program Design Health Barcelona (d·HEALTH Barcelona): a course in innovation in medical technology for healthcare geared towards young people with talent and entrepreneurial spirit who want to help improve the world in the health arena.

Moebio is an initiative that brings together several different training programs of various lengths, all of which aim to promote entrepreneurship at the intersection of technology, biosciences, health and business management. In order to help design advanced programs that can address current challenges from a global perspective, Moebio has an advisory board with the following members: Christer Windeløv-Lidzélius (from Danish entrepreneurial school KaosPilot), John Collins (CIMIT, Boston), Dan E. Azagury (Ciel Medical, Geneva), Yossi Bahagon (Clalit Health Services, Jerusalem), Chia Hwu (Qubop, Silicon Valley), David Maltz (Novartis, Silicon Valley), Lekshmy Parameswaran (Fuelfor, Barcelona-Singapore), Menno Van Dijk (The Amsterdam School of Creative Leadership), Neo Kok-Beng (Stanford Biodesign, Singapore), Lluís Torner (ICFO, Barcelona), and Xavier Verdaguer (Imagine, Barcelona-Silicon Valley), among others.

d·HEALTH Barcelona, the Moebio flagship program, is a groundbreaking masters program accredited by the University of Barcelona that guides multidisciplinary teams through the comprehensive process of identifying new opportunities and developing innovative technology to address major challenges facing the sector around the world. “Probably the best healthcare innovation accelerator in Europe” according to Health Startup Europe, the program collaborates with Hospital Clínic, Hospital Sant Joan de Déu and Institut Guttmann, and will begin its third edition in January 2016. The first two editions have led to several business projects and 100% of the fellows are still working in the health sector.

In 2014, the initiative also launched its MOEBIO Short Programs, training courses taken from the d·HEALTH Barcelona program that are open to all members of the BioRegion and deal with key issues in healthcare, innovation, management and entrepreneurialism.